Article · 18 Dec 2025
Conference abstract
Evaluation of Anti-Leishmanial activity of Photorhabdus and Xenorhabdus cell-free bacterial supernatants
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
According to the World Health Organisation, Leishmaniasis is 9th on the list of most infectious diseases. 350 million people are at risk and 2 million new cases are reported every year. Leishmaniasis is a group of infection caused by Leishmania spp. that is transmitted by vector Phlebotomus spp. In the treatment, usually drugs contain pentavalent antimone complex as an active substance. However, their effectiveness is varied, resistance occurs in time and toxic effects can be seen. There is a great number of studies to discover novel and effective compounds from different organisms. As a result of these studies, identified bioactive novel therapeutics provide oppurtunities to improve new medicines against parasites. In this study, the effects of cell-free supernatants of bacteria in the genus Photorhabdus and Xenorhabdus which are mutualistically associated with obligate insect-pathogenic nematodes were investigated against promastigotes of Leishmania tropica. With this objective, the anti-protozoan effects of 23 different bacterial supernatants were evaluated using Microplate dilution method. The cellfree bacterial supernatants were added to culture medium resulting in concentrations of 10%, 5%, 2.5% and 1.25%. Fifteen of the tested supernatants showed efficacy at varied levels. Xenorhabdus innexi, X. budapestensis, X. miraniensis, X. stockiae, and X. cabanillasii exhibited lethal effect between 89-100% at all concentrations while the rest had dose dependent lethal effect between 10-90%. In line with the results obtained, further studies will be conducted in order to analyze the anti-Leishmanial compounds present in the supernatants. Results will promise new active substances need in the development of new drugs. This work Supported by the Scientific and Technological Research Council of Turkey (TUBITAK) project number 116S387.
Keywords
Subjects
MicrobiologyInfectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Microbiology: Open Access.
Article · 18 Dec 2025
Culture-Based and Molecular Assessment of Microbial Diversity
Article · 18 Dec 2025
Antimicrobial Resistance Detection and Microbial Identification
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Microbiology: Open Access
- SubjectMicrobiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Hatice Ertabaklar”
- BylineArticles whose byline prints “Evren Tileklioglu”
- BylineArticles whose byline prints “Sebnem Hazal Gulsen”
- BylineArticles whose byline prints “Canan Hazir”
- BylineArticles whose byline prints “Sema Ertug”
- BylineArticles whose byline prints “Ibrahim Yildiz”
- BylineArticles whose byline prints “Harun Cimen”
- BylineArticles whose byline prints “Selcuk Hazir”